<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02845362</url>
  </required_header>
  <id_info>
    <org_study_id>SSQVAL</org_study_id>
    <secondary_id>2016/18MAI/215</secondary_id>
    <nct_id>NCT02845362</nct_id>
  </id_info>
  <brief_title>Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases</brief_title>
  <official_title>Validation of the French Version of the Sydney Swallow Questionnaire in Patients With Neuromuscular Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Measurements of dysphagia severity are important when making management decisions and in the&#xD;
      objective evaluation of swallowing impairments. The Sydney Swallow Questionnaire (SSQ) is a&#xD;
      validated self-report inventory using a visual analogue scale. This questionnaire permits a&#xD;
      quantitative, sensitive, specific, repeatable and easily responsive evaluation of dysphagia&#xD;
      in different pathology. Opposed to largely used videofluoroscopy swallowing study and&#xD;
      endoscopy examinations, the SSQ is noninvasive, less expensive, avoids radiation exposure and&#xD;
      enables a readily available assessment. Validated French version is not yet available. In the&#xD;
      first phase of the study the investigators will validated this translation in dysphagic&#xD;
      patients and control. Secondly, the investigators will validate the SSQ in Neuromuscular&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sydney Swallow Questionnaire</measure>
    <time_frame>10 minutes</time_frame>
    <description>The participants were asked to fill out these questionnaires during the outpatient visit.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Dysphagia</condition>
  <condition>Neuromuscular Diseases</condition>
  <arm_group>
    <arm_group_label>Dysphagia assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sydney Swallow Questionnaire</intervention_name>
    <description>The Sydney Swallow Questionnaire (SSQ) is a validated self-report symptom questionnaire, it contains 17 items recorded as visual analogue scales and is a tool specifically designed for evaluation of swallowing difficulties.</description>
    <arm_group_label>Dysphagia assessment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Phase 1:&#xD;
&#xD;
        Group 1:&#xD;
&#xD;
          -  Healthy participants&#xD;
&#xD;
          -  Able to speak, read and write in French&#xD;
&#xD;
          -  Aged at least 18 years old&#xD;
&#xD;
        Group 2:&#xD;
&#xD;
          -  Patients, with symptoms indicative of a deglutition disorder, referred for a&#xD;
             videofluoroscopic study to the Otolaryngology, Head and Neck Surgery Department, Voice&#xD;
             and Swallowing Clinic&#xD;
&#xD;
          -  Able to speak, read and write in French&#xD;
&#xD;
          -  Aged at least 18 years old&#xD;
&#xD;
        Phase 2:&#xD;
&#xD;
          -  Clinical diagnosis of neuromuscular diseases&#xD;
&#xD;
          -  Able to understand French&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Phase 1:&#xD;
&#xD;
        Group 1:&#xD;
&#xD;
          -  History of neurological or neuromuscular disease&#xD;
&#xD;
          -  History of any diagnosticated swallowing disorder&#xD;
&#xD;
        Group 2:&#xD;
&#xD;
          -  Patients who could not be cataloged as dysphagic or non-dysphagic after the&#xD;
             videofluoroscopic study evaluation&#xD;
&#xD;
          -  Patients unable to answer the questionnaire&#xD;
&#xD;
        Phase 2:&#xD;
&#xD;
          -  Patients who could not be cataloged as dysphagic or non-dysphagic&#xD;
&#xD;
          -  Patients unable to answer the questionnaire&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Audag, PT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc, Brussels, Belgium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cliniques universitaires Saint Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>July 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>April 11, 2019</last_update_submitted>
  <last_update_submitted_qc>April 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuromuscular</keyword>
  <keyword>dysphagia</keyword>
  <keyword>Swallowing disorders</keyword>
  <keyword>Questionnaire</keyword>
  <keyword>Assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

